Europe Sepsis Diagnostics Market Forecast to 2028

Report Code : BMIRE00025660 | Region : Europe | Industry : Medical Device | Published Date : 10/Aug/2022
Europe Sepsis Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Instruments, Reagents and Assays, Blood Culture Media, and Software), Technology (Molecular Diagnostics {Polymerase Chain Reaction, Peptide Nucleic Acid-Fluorescent in Situ Hybridization, Syndromic Panel-Based Testing, Microarrays}, Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, and Microbiology), Method (Automated Diagnostics and Conventional Diagnostics), Test Type (Point-of-Care Tests and Laboratory Tests), Pathogen (Bacterial Sepsis, Fungal Sepsis, and Others), and End User (Hospitals, Pathology and Reference Laboratories, and Others)

The Europe sepsis diagnostics market is expected to grow from US$ 193.12 million in 2021 to US$ 360.55 million by 2028; it is estimated to grow at a CAGR of 9.3% from 2021 to 2028.

Technology is a critical parameter in healthcare diagnostics to provide accuracy and save time and resources. In the sepsis diagnosis process, identifying the causative pathogen is essential in selecting appropriate antibiotic therapy as part of the treatment. Molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology are majorly used sepsis diagnostics techniques. Among all, molecular diagnostics (MDx) is an attractive approach to consider for sepsis diagnostics. The increasing adoption of molecular diagnostic technology due to its several advantages, such as high sensitivity, accuracy, and less turnaround time, over other technologies has proved it the gold standard. Therefore, several companies are investing in point-of-care molecular diagnostics to diagnose bacterial and viral pathogens early and for better patient management.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe sepsis diagnostics market. The Europe sepsis diagnostics market is expected to grow at a good CAGR during the forecast period.

Europe Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million )

Europe Sepsis Diagnostics Market Segmentation

The Europe sepsis diagnostics market is segmented based on product, technology, method, test type, pathogen, end user, and country. Based on product, the Europe sepsis diagnostics market is divided into instruments, reagents and assays, blood culture media, and software. The blood culture media dominated the Europe sepsis diagnostics market in 2021. Based on technology, the Europe sepsis diagnostics market is categorized into molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology. The microbiology segment dominated the Europe sepsis diagnostics market in 2021. Based on method, the Europe sepsis diagnostics market is categorized into automated diagnostics and conventional diagnostics. The conventional diagnostics segment dominated the Europe sepsis diagnostics market in 2021. Based on test type, the Europe sepsis diagnostics market is categorized into point-of-care tests and laboratory tests. The laboratory tests segment dominated the Europe sepsis diagnostics market in 2021. Based on pathogen, the Europe sepsis diagnostics market is categorized into bacterial sepsis, fungal sepsis, and others. The bacterial sepsis segment dominated the Europe sepsis diagnostics market in 2021. Based on end user, the Europe sepsis diagnostics market is categorized into hospitals, pathology and reference laboratories, and others. The hospitals segment dominated the Europe sepsis diagnostics market in 2021. Based on country, the Europe sepsis diagnostics market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe sepsis diagnostics market in 2021.

Key players operating in the Europe sepsis diagnostics market include Abbott; F. HOFFMANN-LA ROCHE LTD.; Immunexpress Inc.; BD; Danaher (Beckman Coulter); Luminex Corporation; THERMO FISHER SCIENTIFIC INC.; bioMerieux SA; T2 Biosystems, Inc.; and Axis-Shield Diagnostics Ltd by Altair.

The List of Companies - Europe Sepsis Diagnostics Market

● Abbott

● F. HOFFMANN-LA ROCHE LTD.

● Immunexpress Inc.

● BD

● Danaher (Beckman Coulter)

● Luminex Corporation

● THERMO FISHER SCIENTIFIC INC.

● bioMerieux SA

● T2 Biosystems, Inc

● Axis-Shield Diagnostics Ltd

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Sepsis Diagnostics Market – By Product

1.3.2 Europe Sepsis Diagnostics Market – By Technology

1.3.3 Europe Sepsis Diagnostics Market – By Method

1.3.4 Europe Sepsis Diagnostics Market – By Test Type

1.3.5 Europe Sepsis Diagnostics Market – By Pathogen

1.3.6 Europe Sepsis Diagnostics Market – By End User

1.3.7 Europe Sepsis Diagnostics Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Sepsis Diagnostics Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Europe PEST Analysis

4.3 Experts Opinion

5. Europe Sepsis Diagnostics Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 High Incidence of Sepsis due to Increasing Nosocomial Infections

5.1.2 Increase in Demand for Rapid Diagnostic Tests Leading to Increasing Product Launches

5.2 Market Restraints

5.2.1 Absence of Skilled Professionals

5.3 Market Opportunities

5.3.1 Rise in Funding and Support for Sepsis Diagnostics Research

5.4 Future Trends

5.4.1 Growing Technological Advancements in Sepsis Diagnosis

5.5 Impact Analysis

6. Sepsis Diagnostics Market– Europe Analysis

6.1 Europe Sepsis Diagnostics Market Revenue Forecast and Analysis

7. Europe Sepsis Diagnostics Market – By Product

7.1 Overview

7.2 Europe Sepsis Diagnostics Market, By Product, 2021 & 2028 (%)

7.3 Instruments

7.3.1 Overview

7.3.2 Instruments: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.4 Reagents and Assays

7.4.1 Overview

7.4.2 Reagents and Assays: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.5 Blood Culture Media

7.5.1 Overview

7.5.2 Blood Culture Media: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.6 Software

7.6.1 Overview

7.6.2 Software: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

8. Europe Sepsis Diagnostics Market – By Technology

8.1 Overview

8.2 Europe Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)

8.3 Molecular Diagnostics

8.3.1 Overview

8.3.2 Molecular Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.2.1 Polymerase Chain Reaction

8.3.2.1.1 Overview

8.3.2.1.2 Polymerase Chain Reaction: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization

8.3.2.2.1 Overview

8.3.2.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.2.3 Syndromic Panel-Based Testing

8.3.2.3.1 Overview

8.3.2.3.2 Syndromic Panel-Based Testing: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.2.4 Microarrays

8.3.2.4.1 Overview

8.3.2.4.2 Microarrays: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4 Flow Cytometry

8.4.1 Overview

8.4.2 Flow Cytometry: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.5 Microfluidics

8.5.1 Overview

8.5.2 Microfluidics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.6 Immunoassay

8.6.1 Overview

8.6.2 Immunoassay: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.7 Biomarkers

8.7.1 Overview

8.7.2 Biomarkers: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.8 Microbiology

8.8.1 Overview

8.8.2 Microbiology: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9. Europe Sepsis Diagnostics Market – By Method

9.1 Overview

9.2 Europe Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)

9.3 Automated Diagnostics

9.3.1 Overview

9.3.2 Automated Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.4 Conventional Diagnostics

9.4.1 Overview

9.4.2 Conventional Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10. Europe Sepsis Diagnostics Market – By Test Type

10.1 Overview

10.2 Europe Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)

10.3 Point-of-Care Tests

10.3.1 Overview

10.3.2 Point-of-Care Tests: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.4 Laboratory Tests

10.4.1 Overview

10.4.2 Laboratory Tests: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

11. Europe Sepsis Diagnostics Market – By Pathogen

11.1 Overview

11.2 Europe Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)

11.3 Bacterial Sepsis

11.3.1 Overview

11.3.2 Bacterial Sepsis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

11.4 Fungal Sepsis

11.4.1 Overview

11.4.2 Fungal Sepsis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

11.5 Others

11.5.1 Overview

11.5.2 Others: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

12. Europe Sepsis Diagnostics Market – By End User

12.1 Overview

12.2 Europe Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)

12.3 Hospitals

12.3.1 Overview

12.3.2 Hospitals: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

12.4 Pathology and Reference Laboratories

12.4.1 Overview

12.4.2 Pathology and Reference Laboratories: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

12.5 Others

12.5.1 Overview

12.5.2 Others: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

13. Europe Sepsis Diagnostics Market – By Country Analysis

13.1 Europe: Sepsis Diagnostics Market

13.1.1 Overview

13.1.2 Europe: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)

13.1.2.1 Germany: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.1.1 Overview

13.1.2.1.2 Germany: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.1.3 Germany: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

13.1.2.1.4 Germany: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

13.1.2.1.4.1 Germany: Sepsis Diagnostics Market, by Molecular diagnostics– Revenue and Forecast to 2028 (US$ Million)

13.1.2.1.5 Germany: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

13.1.2.1.6 Germany: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

13.1.2.1.7 Germany: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)

13.1.2.1.8 Germany: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

13.1.2.2 France: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.2.1 Overview

13.1.2.2.2 France: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.2.3 France: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

13.1.2.2.4 France: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

13.1.2.2.4.1 France: Sepsis Diagnostics Market, by Molecular diagnostics – Revenue and Forecast to 2028 (US$ Million)

13.1.2.2.5 France: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

13.1.2.2.6 France: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

13.1.2.2.7 France: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)

13.1.2.2.8 France: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

13.1.2.3 UK: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.3.1 Overview

13.1.2.3.2 UK: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.3.3 UK: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

13.1.2.3.4 UK: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

13.1.2.3.4.1 UK: Sepsis Diagnostics Market, by Molecular Diagnostics– Revenue and Forecast to 2028 (US$ Million)

13.1.2.3.5 UK: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

13.1.2.3.6 UK: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

13.1.2.3.7 UK: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)

13.1.2.3.8 UK: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

13.1.2.4 Italy: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.4.1 Overview

13.1.2.4.2 Italy: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.4.3 Italy: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

13.1.2.4.4 Italy: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

13.1.2.4.4.1 Italy: Sepsis Diagnostics Market, by Molecular Diagnostics– Revenue and Forecast to 2028 (US$ Million)

13.1.2.4.5 Italy: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

13.1.2.4.6 Italy: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

13.1.2.4.7 Italy: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)

13.1.2.4.8 Italy: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

13.1.2.5 Spain: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.5.1 Overview

13.1.2.5.2 Spain: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.5.3 Spain: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

13.1.2.5.4 Spain: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

13.1.2.5.4.1 Spain: Sepsis Diagnostics Market, by Molecular Diagnostics– Revenue and Forecast to 2028 (US$ Million)

13.1.2.5.5 Spain: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

13.1.2.5.6 Spain: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

13.1.2.5.7 Spain: Sepsis Diagnostics Market, by Pathogen– Revenue and Forecast to 2028 (US$ Million)

13.1.2.5.8 Spain: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

13.1.2.6 Rest of Europe: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.6.1 Overview

13.1.2.6.2 Rest of Europe: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.6.3 Rest of Europe: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

13.1.2.6.4 Rest of Europe: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

13.1.2.6.4.1 Rest of Europe: Sepsis Diagnostics Market, by Molecular Diagnostics– Revenue and Forecast to 2028 (US$ Million)

13.1.2.6.5 Rest of Europe: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

13.1.2.6.6 Rest of Europe: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

13.1.2.6.7 Rest of Europe: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)

13.1.2.6.8 Rest of Europe: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

14. Sepsis Diagnostics Market–Industry Landscape

14.1 Overview

14.2 Growth Strategies in the Sepsis Diagnostics Market (%)

14.3 Organic Developments

14.3.1 Overview

14.4 Inorganic Developments

14.4.1 Overview

15. Company Profiles

15.1 Abbott

15.1.1 Key Facts

15.1.2 Business Description

15.1.3 Products and Services

15.1.4 Financial Overview

15.1.5 SWOT Analysis

15.1.6 Key Developments

15.2 F. HOFFMANN-LA ROCHE LTD.

15.2.1 Key Facts

15.2.2 Business Description

15.2.3 Products and Services

15.2.4 Financial Overview

15.2.5 SWOT Analysis

15.2.6 Key Developments

15.3 Immunexpress Inc.

15.3.1 Key Facts

15.3.2 Business Description

15.3.3 Products and Services

15.3.4 Financial Overview

15.3.5 SWOT Analysis

15.3.6 Key Developments

15.4 BD

15.4.1 Key Facts

15.4.2 Business Description

15.4.3 Products and Services

15.4.4 Financial Overview

15.4.5 SWOT Analysis

15.4.6 Key Developments

15.5 Danaher (Beckman Coulter)

15.5.1 Key Facts

15.5.2 Business Description

15.5.3 Products and Services

15.5.4 Financial Overview

15.5.5 SWOT Analysis

15.5.6 Key Developments

15.6 Luminex Corporation

15.6.1 Key Facts

15.6.2 Business Description

15.6.3 Products and Services

15.6.4 Financial Overview

15.6.5 SWOT Analysis

15.6.6 Key Developments

15.7 THERMO FISHER SCIENTIFIC INC.

15.7.1 Key Facts

15.7.2 Business Description

15.7.3 Products and Services

15.7.4 Financial Overview

15.7.5 SWOT Analysis

15.7.6 Key Developments

15.8 bioMerieux SA

15.8.1 Key Facts

15.8.2 Business Description

15.8.3 Products and Services

15.8.4 Financial Overview

15.8.5 SWOT Analysis

15.8.6 Key Developments

15.9 T2 Biosystems, Inc.

15.9.1 Key Facts

15.9.2 Business Description

15.9.3 Products and Services

15.9.4 Financial Overview

15.9.5 SWOT Analysis

15.9.6 Key Developments

15.10 Axis-Shield Diagnostics Ltd

15.10.1 Key Facts

15.10.2 Business Description

15.10.3 Products and Services

15.10.4 Financial Overview

15.10.5 SWOT Analysis

15.10.6 Key Developments

16. Appendix

16.1 About The Insight Partners

16.2 Glossary of Terms

LIST OF TABLES.

Table 1.             Germany: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 2.             Germany: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 3.             Germany: Sepsis Diagnostics Market, by Molecular diagnostics – Revenue and Forecast to 2028 (US$ Million)

Table 4.             Germany: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 5.             Germany: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

Table 6.             Germany: Sepsis Diagnostics Market, by Pathogen– Revenue and Forecast to 2028 (US$ Million)

Table 7.             Germany: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 8.             France: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 9.             France: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 10.          France: Sepsis Diagnostics Market, by Molecular diagnostics – Revenue and Forecast to 2028 (US$ Million)

Table 11.          France: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 12.          France: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

Table 13.          France: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)

Table 14.          France: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 15.          UK: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 16.          UK: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 17.          UK: Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)

Table 18.          UK: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 19.          UK: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

Table 20.          UK: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)

Table 21.          UK: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 22.          Italy: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 23.          Italy: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 24.          Italy: Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)

Table 25.          Italy: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 26.          Italy: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

Table 27.          Italy: Sepsis Diagnostics Market, by Pathogen– Revenue and Forecast to 2028 (US$ Million)

Table 28.          Italy: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 29.          Spain: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 30.          Spain: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 31.          Spain: Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)

Table 32.          Spain: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 33.          Spain: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

Table 34.          Spain: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)

Table 35.          Spain: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 36.          Rest of Europe: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 37.          Rest of Europe: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 38.          Rest of Europe: Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)

Table 39.          Rest of Europe: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 40.          Rest of Europe: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

Table 41.          Rest of Europe: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)

Table 42.          Rest of Europe: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 43.          Organic Developments in the Sepsis Diagnostics Market

Table 44.          Inorganic Developments in the Sepsis Diagnostics Market

Table 45.          Glossary of Terms

The List of Companies - Europe Sepsis Diagnostics Market

● Abbott

● F. HOFFMANN-LA ROCHE LTD.

● Immunexpress Inc.

● BD

● Danaher (Beckman Coulter)

● Luminex Corporation

● THERMO FISHER SCIENTIFIC INC.

● bioMerieux SA

● T2 Biosystems, Inc

● Axis-Shield Diagnostics Ltd

Reason To Buy

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe sepsis diagnostics market.

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the Europe sepsis diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe sepsis diagnostics market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

AVAILABLE CUSTOMIZATION RESEARCH METHODOLOGY REQUEST FOR TOC FREE SAMPLE REPORT
CHOOSE LICENCE TYPE
(Europe Sepsis Diagnostics Market Forecast to 2028 )
  • Single User Price $3,000$2,400
  • Site Price $4,000$3,200
  • Enterprise Price $5,000$4,000
Buy Now Add to Cart
REQUEST FOR TOC
SPEAK TO ANALYST
FREE SAMPLE
REPORT
INQUIRE BEFORE
BUYING
TOP
Quick Enquiry